Non-Current Assets
Long- term Investments
Gilead Sciences Long- term Investments decreased by 66.9% to $983.00M in Q1 2026 compared to the prior quarter. Over 5 years (FY 2020 to FY 2025), Long- term Investments shows an upward trend with a 42.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2015
Last reportedQ1 2026May 7, 2026
Metric ID:
non_current_assets_marketable_securities_noncurrentHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $836.00M | $1.10B | $1.31B | $1.43B | $1.34B | $1.28B | $1.25B | $1.33B | $1.33B | $1.16B | $1.16B | $0.00 | $0.00 | $0.00 | $0.00 | $1.91B | $2.01B | $2.97B | $983.00M |
| QoQ Change | — | +31.5% | +19.1% | +9.0% | -6.3% | -4.1% | -2.9% | +6.6% | +0.5% | -13.3% | +0.6% | -100.0% | — | — | — | — | +4.8% | +48.3% | -66.9% |
| YoY Change | — | — | — | — | +59.9% | +16.7% | -4.9% | -7.0% | -0.2% | -9.8% | -6.6% | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — |
Range$0.00 – $2.97B
CAGR+3.7%
Avg YoY Growth-32.0%
Median YoY Growth-7.0%
Long- term Investments at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's long- term investments?
- Gilead Sciences (GILD) reported long- term investments of $983.00M in Q1 2026.
- What is the long-term trend for Gilead Sciences's long- term investments?
- Over 5 years (2020 to 2025), Gilead Sciences's long- term investments has grown at a 42.7% compound annual growth rate (CAGR), from $502.00M to $2.97B.